EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet?

Elisa Arrigo, Stefano Comità, Pasquale Pagliaro iD, Claudia Penna, Daniele Mancardi iD

International Journal of Molecular Sciences · 05.08.2023 · 24 (15) · 12480

DOI: 10.3390/ijms241512480 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.08.2023. Verfasst von Elisa Arrigo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Biological Sciences, University of Torino, 10124 Turin, Italy. Hauptthemen laut MEDLINE: Gasotransmitters, Hydrogen Sulfide, Cardiovascular System. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intesa San Paolo, Fondo Beneficenza San Paolo, Fondo di beneficenza San Paolo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemia is the underlying mechanism in a wide variety of acute and persistent pathologies. As such, understanding the fine intracellular events occurring during (and after) the restriction of blood supply is pivotal to improving the outcomes in clinical settings. Among others, gaseous signaling molecules constitutively produced by mammalian cells (gasotransmitters) have been shown to be of potential interest for clinical treatment of ischemia/reperfusion injury. Nitric oxide (NO and its sibling, HNO), hydrogen sulfide (H2S), and carbon monoxide (CO) have long been proven to be cytoprotective in basic science experiments, and they are now awaiting confirmation with clinical trials. The aim of this work is to review the literature and the clinical trials database to address the state of development of potential therapeutic applications for NO, H2S, and CO and the clinical scenarios where they are more promising.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GasotransmittersHydrogen SulfideCardiovascular SystemAnimalsNitric OxideSignal TransductionCarbon MonoxideMammals

Stichwörter der Autor:innen

carbon monoxidecardioprotectionclinical trialshydrogen sulfideischemianitric oxidereperfusion

Substanzen

GasotransmittersHydrogen SulfideNitric OxideCarbon Monoxide

Autor:innen und Institutionen

  • Department of Clinical and Biological Sciences, University of Torino, 10124 Turin, Italy.

ORCID-Profile: Pasquale Pagliaro, Daniele Mancardi

Förderung

  • Intesa San Paolo
  • Fondo Beneficenza San Paolo
  • Fondo di beneficenza San Paolo

Zitieren

APA

Arrigo, E., Comità, S., Pagliaro, P., Penna, C., & Mancardi, D. (2023). Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet?. International Journal of Molecular Sciences, 24(15), 12480. https://doi.org/10.3390/ijms241512480

Vancouver

Arrigo E, Comità S, Pagliaro P, Penna C, Mancardi D. Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet?. International Journal of Molecular Sciences. 2023;24(15):12480. doi:10.3390/ijms241512480

BibTeX
@article{Arrigo2023,
  author = {Arrigo, Elisa and Comità, Stefano and Pagliaro, Pasquale and Penna, Claudia and Mancardi, Daniele},
  title = {Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet?},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {15},
  pages = {12480},
  doi = {10.3390/ijms241512480}
}
Kostenlos starten →